Aurobindo Pharma gets USFDA nod for two generic drugs savita18 Jan 2016 10:48 AM ISTNew Delhi: Drug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market its Tranexamic acid injection and Paricalcitol...
USFDA observations for Shendra facility not critical: Wockhardt savita18 Jan 2016 9:58 AM ISTNew Delhi: The nine observations received by Wockhardt for its Shendra facility in Aurangabad from the US health regulator are not 'critical' in...
USFDA makes 9 observations over Wockhardt's plant in Shendra savita16 Jan 2016 10:50 AM ISTNew Delhi: The USFDA has made nine 'observations' highlighting violations of its norms at homegrown drug maker Wockhardt's new facility at Shendra in...
Vyome Bio's acne drug VB 1953 gets USFDA nod savita15 Jan 2016 2:44 PM ISTMumbai: Bio-pharmaceutical company Vyome Biosciences said the US Food and Drug Administration (USFDA) has cleared its investigational new drug (IND)...
State agencies in Delhi and Mumbai crack down on online drug sales Pooja15 Jan 2016 11:40 AM ISTEven as the govt and health authorities contemplate over the issue of regulating the sale of online medicines; the state agencies in Delhi and Mumbai...
Chemists association opposes hike in license fee Pooja15 Jan 2016 9:30 AM ISTThe recent proposal of Drug Controller General of India (DCGI) on hike in license fee of chemists , has been opposed in Punjab and Nagpur.Apparently,...
FDA rejects BioMarin's muscle wasting drug; Sarepta drug in focus savita15 Jan 2016 9:15 AM ISTThe U.S. Food and Drug Administration rejected BioMarin Pharmaceutical Inc's drug to treat a rare muscle-wasting disorder, shifting investor focus to...
Over 200 drugs under development, top 50 with $30 billion potential: Cipla savita14 Jan 2016 11:15 AM ISTNew Delhi : Charting out its next phase of growth, homegrown drug major Cipla is banking on over 200 drugs under development out of which "top 50...
Pfizer says its CAR T cancer therapy could outshine rivals savita14 Jan 2016 11:10 AM ISTNEW YORK, - Pfizer Inc aims to drive profits in coming years with more-responsive and easier-to-manufacture new cancer treatments.With its French...
Pfizer, Allergan say combined drug pipeline 'underappreciated' savita13 Jan 2016 4:46 PM ISTNew York : The research chiefs of betrothed drugmakers Pfizer Inc and Allergan say the proposed combination of their experimental drugs deserves more...
Glenmark eyes 20 percent growth per annum over the next decade savita13 Jan 2016 3:47 PM ISTNEW DELHI: Glenmark Pharmaceuticals aims to keep growing its base business by 18-20 per cent per annum over the next ten years.The drug maker also...
Strides Shasun gets CCI nod to buy Sun Pharma's two divisions savita13 Jan 2016 11:05 AM ISTNEW DELHI: Strides Shasun today got CCI's approval to acquire Sun Pharmaceutical's two business divisions in India for Rs 165 crore.In September last...
